Vectura Group

Vectura Group company information, Employees & Contact Information

Explore related pages

Vectura Group email format Vectura Group management contacts

Related company profiles:

Vectura is a provider of innovative inhaled drug delivery services that enable partners to bring their medicines to patients. With differentiated proprietary technology and pharmaceutical development expertise, Vectura is one of the few companies globally with the device, formulation and development capabilities to deliver a broad range of complex inhaled therapies. Vectura has thirteen key inhaled and eleven non-inhaled products marketed by partners with global royalty streams, and a diverse partnered portfolio of drugs in clinical development. Our partners include Hikma, Novartis, Sandoz (a division of Novartis AG), Mundipharma, Kyorin, GSK, Bayer, Chiesi, Almirall, and Tianjin KingYork. For further information, please visit Vectura's website at www.vectura.com

Company Details

Employees
291
Address
One Prospect West, Chippenham,wiltshire Sn14 6fh,united Kingdom
Phone
4401249667700
Email
in****@****ura.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
vectura.com
Keywords
Pharmaceutical, Product development, Formulation, Drug delivery, Respiratory, Life Sciences, Medical Devices, Inhalers, Inhalation, CDMO.
HQ
Chippenham, Wiltshire
Competitors
Cambridge Healthcare Research, Aspeya, ProImmune, Lonza, Oxford BioTherapeutics, Fertin Pharma A/S, Porvair Sciences, Richmond Pharmacology, Phillips Medisize, Prima Mente.
Looking for a particular Vectura Group employee's phone or email?

Vectura Group Questions

News

Phillips Medisize Adds Vectura’s Inhalation Drug Delivery Capabilities - respiratory-therapy.com

Phillips Medisize Adds Vectura’s Inhalation Drug Delivery Capabilities respiratory-therapy.com

Philip Morris to sell Vectura for $198 mln after health shift criticism - Reuters

Philip Morris to sell Vectura for $198 mln after health shift criticism Reuters

‘Unresolvable conflict’: are links to big tobacco changing inhaler prescribing? - The Pharmaceutical Journal

‘Unresolvable conflict’: are links to big tobacco changing inhaler prescribing? The Pharmaceutical Journal

Investors Press Releases | PMI - Philip Morris International

Investors Press Releases | PMI Philip Morris International

Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge - PR Newswire

Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge PR Newswire

Phillips Medisize to acquire Vectura from Philip Morris - Drug Delivery Business

Phillips Medisize to acquire Vectura from Philip Morris Drug Delivery Business

Molex to acquire drug device company Vectura - Medical Device Network

Molex to acquire drug device company Vectura Medical Device Network

Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation - Business Wire

Molex, a Parent to Phillips Medisize, Announces Agreement to Acquire the Vectura Group Limited, Expanding Its Drug Delivery Capabilities in Inhalation Business Wire

Philip Morris strikes $1.45B deal for Vectura, sending another would-be buyer back to the drawing board - Fierce Pharma

Philip Morris strikes $1.45B deal for Vectura, sending another would-be buyer back to the drawing board Fierce Pharma

Molex Closes Acquisition of Vectura Group - Contract Pharma

Molex Closes Acquisition of Vectura Group Contract Pharma

Phillips Medisize Boosts Medical Inhaler Portfolio With Vectura Acquisition - PlasticsToday

Phillips Medisize Boosts Medical Inhaler Portfolio With Vectura Acquisition PlasticsToday

Vectura, Kinaset Therapeutics set to develop inhaled asthma drug - PharmaTimes

Vectura, Kinaset Therapeutics set to develop inhaled asthma drug PharmaTimes

Vectura board unanimously accepts Philip Morris’s controversial takeover bid - The Guardian

Vectura board unanimously accepts Philip Morris’s controversial takeover bid The Guardian

Philip Morris to Sell Inhalation Drug Delivery Company Vectura - respiratory-therapy.com

Philip Morris to Sell Inhalation Drug Delivery Company Vectura respiratory-therapy.com

Phillips Medisize completes Vectura acquisition from Philip Morris - Drug Delivery Business

Phillips Medisize completes Vectura acquisition from Philip Morris Drug Delivery Business

UK pharma group Vectura agrees $1.4 bln takeover by Carlyle - Reuters

UK pharma group Vectura agrees $1.4 bln takeover by Carlyle Reuters

NHS spends £430m on inhalers linked to Philip Morris since Vectura takeover - The Pharmaceutical Journal

NHS spends £430m on inhalers linked to Philip Morris since Vectura takeover The Pharmaceutical Journal

Vectura, after reinventing itself as a CDMO, accepts $1.4B buyout offer from Carlyle - Fierce Pharma

Vectura, after reinventing itself as a CDMO, accepts $1.4B buyout offer from Carlyle Fierce Pharma

Philip Morris gets over a fifth of Vectura shares in takeover tender offer - Reuters

Philip Morris gets over a fifth of Vectura shares in takeover tender offer Reuters

Philip Morris seals deal for UK's Vectura despite health group concerns - Reuters

Philip Morris seals deal for UK's Vectura despite health group concerns Reuters

Tobacco firm PMI divests Vectura at a loss after backlash - pharmaphorum

Tobacco firm PMI divests Vectura at a loss after backlash pharmaphorum

Philip Morris International Inc. Announces Firm Offer to Acquire Vectura Group plc; Acquisition Accelerates PMI’s Beyond Nicotine Strategy and Expands its Product Pipeline Development Capabilities in Inhaled Therapeutics - Philip Morris International

Philip Morris International Inc. Announces Firm Offer to Acquire Vectura Group plc; Acquisition Accelerates PMI’s Beyond Nicotine Strategy and Expands its Product Pipeline Development Capabilities in Inhaled Therapeutics Philip Morris International

Vectura Acquisition Means Tobacco Giant PMI Will Profit Twice From Smoking - Stopping Tobacco Organizations and Products

Vectura Acquisition Means Tobacco Giant PMI Will Profit Twice From Smoking Stopping Tobacco Organizations and Products

Philip Morris Is Buying An Asthma Inhaler Company. Health Groups Are Suspicious - NPR

Philip Morris Is Buying An Asthma Inhaler Company. Health Groups Are Suspicious NPR

EnBiotix, Inc. Closes $11M Pre-Merger Financing - GlobeNewswire

EnBiotix, Inc. Closes $11M Pre-Merger Financing GlobeNewswire

PMI to Record £220 Million Loss on Vectura Sale - Tobacco Reporter

PMI to Record £220 Million Loss on Vectura Sale Tobacco Reporter

Health firm Vectura faced with choice between Carlyle and Philip Morris - The Guardian

Health firm Vectura faced with choice between Carlyle and Philip Morris The Guardian

Vectura: Marlboro giant seals takeover of UK inhaler firm - BBC

Vectura: Marlboro giant seals takeover of UK inhaler firm BBC

Inhaler firm Vectura removed from conference over Philip Morris takeover - The Guardian

Inhaler firm Vectura removed from conference over Philip Morris takeover The Guardian

Vectura cans VR475 after it fails phase 3 asthma test - Fierce Biotech

Vectura cans VR475 after it fails phase 3 asthma test Fierce Biotech

PMI Sells Vectura at a Loss - Tobacco Reporter

PMI Sells Vectura at a Loss Tobacco Reporter

Philip Morris International makes £1bn offer for UK pharma firm Vectura | Mergers and acquisitions - The Guardian

Philip Morris International makes £1bn offer for UK pharma firm Vectura | Mergers and acquisitions The Guardian

Vectura seeks another $44M in GSK patent win - Drug Delivery Business

Vectura seeks another $44M in GSK patent win Drug Delivery Business

US tobacco giant Philip Morris International snaps up 22.6% stake in Vectura - The Guardian

US tobacco giant Philip Morris International snaps up 22.6% stake in Vectura The Guardian

Health charities voice concern at Philip Morris’s £1bn bid for Vectura - The Guardian

Health charities voice concern at Philip Morris’s £1bn bid for Vectura The Guardian

Carlyle ups bid for inhaler firm Vectura, trumping tobacco giant Philip Morris - The Guardian

Carlyle ups bid for inhaler firm Vectura, trumping tobacco giant Philip Morris The Guardian

Vectura’s Severe Asthma Treatment Fails in Phase III Trial - BioSpace

Vectura’s Severe Asthma Treatment Fails in Phase III Trial BioSpace

Vectura wins patent litigation battle against GSK, awarded $89.7M - PharmaTimes

Vectura wins patent litigation battle against GSK, awarded $89.7M PharmaTimes

Philip Morris Vies With Carlyle to Buy Asthma Drugmaker Vectura - Bloomberg.com

Philip Morris Vies With Carlyle to Buy Asthma Drugmaker Vectura Bloomberg.com

UK’s Vectura Buys Skyepharma for $620 Million to Create Powerful Respiratory Company - BioSpace

UK’s Vectura Buys Skyepharma for $620 Million to Create Powerful Respiratory Company BioSpace

Vectura board backs Philip Morris takeover bid over The Carlyle Group offer - PMLiVE

Vectura board backs Philip Morris takeover bid over The Carlyle Group offer PMLiVE

After buying health company Vectura, tobacco giant Philip Morris will profit from treating the illnesses its products create - The Conversation

After buying health company Vectura, tobacco giant Philip Morris will profit from treating the illnesses its products create The Conversation

Philip Morris raises offer in bidding war for UK inhaler group Vectura - Financial Times

Philip Morris raises offer in bidding war for UK inhaler group Vectura Financial Times

Marlboro owner’s takeover of Vectura “makes strategic sense” - Bayes Business School

Marlboro owner’s takeover of Vectura “makes strategic sense” Bayes Business School

Vectura’s Flutiform flunks phase III COPD test - PMLiVE

Vectura’s Flutiform flunks phase III COPD test PMLiVE

Blow to PMI as top executives quit Vectura - The Times

Blow to PMI as top executives quit Vectura The Times

UK inhaler firm Vectura backs £1bn bid by Marlboro-maker - BBC

UK inhaler firm Vectura backs £1bn bid by Marlboro-maker BBC

Companies like Vectura Group

Fertin Pharma A/S logo - Similar company to Vectura Group

Fertin Pharma A/S

746
Cambridge Healthcare Research logo - Similar company to Vectura Group

Cambridge Healthcare...

157
Phillips Medisize logo - Similar company to Vectura Group

Phillips Medisize

2.86K
Aspeya logo - Similar company to Vectura Group

Aspeya

127
Lonza logo - Similar company to Vectura Group

Lonza

18.17K
Oxford BioTherapeutics logo - Similar company to Vectura Group

Oxford Biotherapeutics

51
ProImmune logo - Similar company to Vectura Group

Proimmune

52
Prima Mente logo - Similar company to Vectura Group

Prima Mente

18
Porvair Sciences logo - Similar company to Vectura Group

Porvair Sciences

46
Richmond Pharmacology logo - Similar company to Vectura Group

Richmond Pharmacology

195

Top Vectura Group Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant